மர்ஸர் ரூபாய்கள் எலும்பியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share:
NEW YORK, Feb. 16, 2021 (GLOBE NEWSWIRE)
PAVmed Inc. (NASDAQ:PAVM, PAVMZ)) (the Company or PAVmed ), a highly differentiated, multi-product, commercial-stage medical technology company, today announced that the first U.S. patient recently underwent successful carpal tunnel release using its CarpX
® minimally invasive carpal tunnel device.
CarpX relieves the symptoms of Carpal Tunnel Syndrome (CTS) in a rapid, minimally invasive, office-based procedure that speeds patients recovery. CTS is a common workplace-related condition that causes chronic pain to patients and, as the top driver of workmen s compensation claims, imposes high costs on society.
The patient presented with symptoms of carpal tunnel syndrome to Dr. Edward J. Armbruster of Mercer-Bucks Orthopaedics, P.C., in greater Philadelphia, who performed minimally invasive carpal tunnel release using the CarpX device. In marked contrast to typical recovery times of up to several months fol ....

New Zealand , United States , Edwardj Armbruster , Shaun Oneil , Katie Gallagher , Lishan Aklog , Mike Havrilla , Lucid Diagnostics Inc , Gi Health Esoguard , Drug Administration , Exchange Commission , Pavmed Inc , Globe Newswire Pavmed Inc , Accurate Infusion Platform Technology , Carpal Tunnel Syndrome , Mercer Bucks Orthopaedics , Chief Medical Officer , Chief Executive , Esophageal Cell Collection Device , Esophageal Ablation Device , Minimally Invasive Interventions , Minimally Invasive Device , Infusion Therapy , Implantable Intraosseus Vascular Access Device , Highly Accurate Infusion Platform Technology , Emerging Innovations ,